Pyruvate dehydrogenase phosphatase (PDP) (PDP)

Pyruvate dehydrogenase phosphatase (PDP) is a mitochondrial enzyme that plays a pivotal role in cellular energy metabolism by dephosphorylating and activating the pyruvate dehydrogenase complex (PDC) (UniProt: P78527). This activation is the rate-limiting step in the conversion of pyruvate into acetyl-CoA, effectively linking glycolysis to the tricarboxylic acid (TCA) cycle (PubMed: 23102186). The enzyme consists of two catalytic isoforms, PDP1 and PDP2, which are regulated by calcium ions and insulin signaling respectively (PubMed: 12145300). PDP1 is primarily expressed in skeletal muscle and the heart, while PDP2 is found in the liver and adipose tissue (PubMed: 15615697). Genetic mutations leading to PDP deficiency result in persistent lactic acidosis and neurological dysfunction (StatPearls: NBK554420). In metabolic diseases like type 2 diabetes, reduced PDP activity contributes to impaired glucose oxidation and insulin resistance (PubMed: 11903350). In oncology, PDP is often downregulated, promoting the Warburg effect where cancer cells rely on glycolysis even in the presence of oxygen (PubMed: 28611100). Therapeutic strategies often focus on activating PDP or inhibiting its opposing kinases to restore mitochondrial function (PubMed: 25588851). While direct small-molecule activators are in early research stages, the enzyme remains a high-interest target for metabolic and degenerative diseases.

Other names

Pyruvate dehydrogenase (lipoamide)-phosphatase[Pyruvate dehydrogenase (acetyl-transferring)]-phosphatasePDH phosphatasePDP1PDP2PDPC

Activation of the pyruvate dehydrogenase complex through the dephosphorylation of the E1-alpha subunit (PDHA1), thereby promoting the oxidative decarboxylation of pyruvate to acetyl-CoA.